Lenz & Staehelin advised co-lead investors Samsara Biocapital and Lightspeed Venture Partners as their Swiss counsel. VISCHER advised ImmunOs. Walder Wyss advises Gimv. ImmunOs Therapeutics AG,...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised Vail Resorts on this transaction. Advestra advised Andermatt Swiss Alps AG (ASA). Vail Resorts (NYSE: MTN) has announced that it will acquire...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised Vail Resorts on this transaction. Advestra advised Andermatt Swiss Alps AG (ASA). Vail Resorts (NYSE: MTN) has announced that it will acquire...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised Prysmian Group on the deal. Tavernier Tschanz acted as counsel to the sellers in this transaction, including Renaissance PME fondation suisse d’investissement,...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised Vicat and Vigier Holding in this transaction. MLL advised Müller-Steinag. Vicat Group, the Euronext listed producer of cement, concrete and aggregates announced...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin acted as counsel to Fahrzeug-Werke Lueg AG. Fahrzeug-Werke LUEG AG (one of the largest mobility provider in Germany and a leading sales and...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin acted as lead counsel to Maus Frères in this transaction, while Niederer Kraft Frey advised Coop. Maus Frères and Coop-Gruppe Genossenschaft announced the...
You must be a Standard 1 Year member to access this content.
Bär & Karrer has acted as lead counsel to Lonza in this transaction. Lenz & Staehelin, Freshfields Bruckhaus Deringer, Kirkland & Ellis and Elvinger Hoss Prussen...
You must be a Standard 1 Year member to access this content.
